# Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis

> **NCT06575361** · NA · COMPLETED · sponsor: **Peking University First Hospital** · enrollment: 365 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Combination of targeted biopsy and systematic biopsy

## Key facts

- **NCT ID:** NCT06575361
- **Lead sponsor:** Peking University First Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-08-31
- **Target enrollment:** 365 (ACTUAL)
- **Last updated:** 2026-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06575361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06575361, "Comprehensive Evaluation of MRI-AI in Prostate Cancer Diagnosis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06575361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*